Oxygen, a source of life and stress

FEBS Letters

Volumn 581, Issue 19, 2007, Pages 3582-3591

  Brahimi Horn, M Christiane ^a   Pouysségur, Jacques ^a  

^a UNIVERSITÉ CÔTE D'AZUR   (France)

Author keywords

Angiogenesis; Cancer; Carbonic anhydrase; Factor inhibiting HIF; Hypoxia inducible factor; Oxygen sensor; pH; Prolyl hydroxylase domain; Tumour metabolism

Indexed keywords

ADENOSINE TRIPHOSPHATE; AUTOCRINE MOTILITY FACTOR; CADHERIN; CARBONATE DEHYDRATASE; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN BINDING PROTEIN; CYTOCHROME C OXIDASE; CYTOCHROME C OXIDASE 2; GROWTH FACTOR; HEAT SHOCK PROTEIN 90; HISTONE ACETYLTRANSFERASE PCAF; HYPOXIA INDUCIBLE FACTOR 1; HYPOXIA INDUCIBLE FACTOR 1ALPHA; HYPOXIA INDUCIBLE FACTOR 1BETA; INTEGRIN; LACTATE DEHYDROGENASE; LACTATE DEHYDROGENASE ISOENZYME 5; MAMMALIAN TARGET OF RAPAMYCIN; OXYGEN; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; PROTEIN P53; PYRUVATE DEHYDROGENASE; PYRUVATE DEHYDROGENASE KINASE 1; SELECTIN; SODIUM PROTON EXCHANGE PROTEIN; SODIUM PROTON EXCHANGE PROTEIN 1; SUCCINATE DEHYDROGENASE; TRANSCRIPTION FACTOR; UBIQUITIN PROTEIN LIGASE E3; UNCLASSIFIED DRUG; UNINDEXED DRUG;

CANCER; CELL HYPOXIA; CELL METABOLISM; CELL PH; HOMEOSTASIS; HUMAN; HYPEROXIA; ISCHEMIA; NONHUMAN; OXYGEN CONSUMPTION; OXYGEN TENSION; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REGULATORY MECHANISM; RETROLENTAL FIBROPLASIA; SHORT SURVEY; SIGNAL TRANSDUCTION; STRESS; SURVIVAL; SYSTEMATIC REVIEW;

ACIDOSIS; ANOXIA; GLUCOSE; HEAT-SHOCK RESPONSE; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1; NEOPLASMS; OXYGEN; PARTIAL PRESSURE; SIGNAL TRANSDUCTION;

EID: 34447504549     PISSN: 00145793     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.febslet.2007.06.018     Document Type: Short Survey

References (71)

1. Astrom K., Cohen J.E., Willett-Brozick J.E., Aston C.E., and Baysal B.E. Altitude is a phenotypic modifier in hereditary paraganglioma type 1: evidence for an oxygen-sensing defect. Hum. Genet. 113 (2003) 228-237
2. Ferrara N., and Kerbel R.S. Angiogenesis as a therapeutic target. Nature 438 (2005) 967-974
3. Braun R.D., Lanzen J.L., Snyder S.A., and Dewhirst M.W. Comparison of tumor and normal tissue oxygen tension measurements using OxyLite or microelectrodes in rodents. Am. J. Physiol. Heart Circ. Physiol. 280 (2001) H2533-H2544
4. Yu D.Y., and Cringle S.J. Retinal degeneration and local oxygen metabolism. Exp. Eye Res. 80 (2005) 745-751
5. Erecinska M., and Silver I.A. Tissue oxygen tension and brain sensitivity to hypoxia. Respir. Physiol. 128 (2001) 263-276
6. Folkman J., Hahnfeldt P., and Hlatky L. Cancer: looking outside the genome. Nat. Rev. Mol. Cell Biol. 1 (2000) 76-79
7. Gatenby R.A., and Gillies R.J. Why do cancers have high aerobic glycolysis?. Nat. Rev. Cancer 4 (2004) 891-899
8. Vaupel P. Tumor microenvironmental physiology and its implications for radiation oncology. Semin. Radiat. Oncol. 14 (2004) 198-206
9. Rajendran J.G., Mankoff D.A., O'Sullivan F., Peterson L.M., Schwartz D.L., Conrad E.U., Spence A.M., Muzi M., Farwell D.G., and Krohn K.A. Hypoxia and glucose metabolism in malignant tumors: evaluation by [18F]fluoromisonidazole and [18F]fluorodeoxyglucose positron emission tomography imaging. Clin. Cancer Res. 10 (2004) 2245-2252
10. Semenza G.L., Nejfelt M.K., Chi S.M., and Antonarakis S.E. Hypoxia-inducible nuclear factors bind to an enhancer element located 3′ to the human erythropoietin gene. Proc. Natl. Acad. Sci. USA 88 (1991) 5680-5684
11. Berra E., Ginouves A., and Pouyssegur J. The hypoxia-inducible-factor hydroxylases bring fresh air into hypoxia signalling. EMBO Rep. 7 (2006) 41-45
12. Schofield C.J., and Ratcliffe P.J. Signalling hypoxia by HIF hydroxylases. Biochem. Biophys. Res. Commun. 338 (2005) 617-626
13. Brahimi-Horn C., Mazure N., and Pouyssegur J. Signalling via the hypoxia-inducible factor-1alpha requires multiple posttranslational modifications. Cell Signal. 17 (2005) 1-9
14. Liu Y.V., and Semenza G.L. RACK1 vs. HSP90: competition for HIF-1 alpha degradation vs. stabilization. Cell Cycle 6 (2007) 656-659
15. Baird N.A., Turnbull D.W., and Johnson E.A. Induction of the heat shock pathway during hypoxia requires regulation of heat shock factor by hypoxia-inducible factor-1. J. Biol. Chem. 281 (2006) 38675-38681
16. Lau K.W., Tian Y.M., Raval R.R., Ratcliffe P.J., and Pugh C.W. Target gene selectivity of hypoxia-inducible factor-alpha in renal cancer cells is conveyed by post-DNA-binding mechanisms. Br. J. Cancer 96 (2007) 1284-1292
17. Aprelikova O., Chandramouli G.V., Wood M., Vasselli J.R., Riss J., Maranchie J.K., Linehan W.M., and Barrett J.C. Regulation of HIF prolyl hydroxylases by hypoxia-inducible factors. J. Cell Biochem. 92 (2004) 491-501
18. Gordan J.D., Bertout J.A., Hu C.J., Diehl J.A., and Simon M.C. HIF-2alpha promotes hypoxic cell proliferation by enhancing c-myc transcriptional activity. Cancer Cell 11 (2007) 335-347
19. Wang V., Davis D.A., Haque M., Huang L.E., and Yarchoan R. Differential gene up-regulation by hypoxia-inducible factor-1alpha and hypoxia-inducible factor-2alpha in HEK293T cells. Cancer Res. 65 (2005) 3299-3306
20. Rankin E.B., Biju M.P., Liu Q., Unger T.L., Rha J., Johnson R.S., Simon M.C., Keith B., and Haase V.H. Hypoxia-inducible factor-2 (HIF-2) regulates hepatic erythropoietin in vivo. J. Clin. Invest. 117 (2007) 1068-1077
21. Brahimi-Horn M.C., and Pouyssegur J. The hypoxia-inducible factor and tumor progression along the angiogenic pathway. Int. Rev. Cytol. 242 (2005) 157-213
22. Dayan F., Roux D., Brahimi-Horn M.C., Pouyssegur J., and Mazure N.M. The oxygen sensor factor-inhibiting hypoxia-inducible factor-1 controls expression of distinct genes through the bifunctional transcriptional character of hypoxia-inducible factor-1alpha. Cancer Res. 66 (2006) 3688-3698
23. Fantin V.R., St-Pierre J., and Leder P. Attenuation of LDH-A expression uncovers a link between glycolysis, mitochondrial physiology, and tumor maintenance. Cancer Cell 9 (2006) 425-434
24. Blum R., Jacob-Hirsch J., Amariglio N., Rechavi G., and Kloog Y. Ras inhibition in glioblastoma down-regulates hypoxia-inducible factor-1alpha, causing glycolysis shutdown and cell death. Cancer Res. 65 (2005) 999-1006
25. Kim J.W., Zeller K.I., Wang Y., Jegga A.G., Aronow B.J., O'Donnell K.A., and Dang C.V. Evaluation of myc E-box phylogenetic footprints in glycolytic genes by chromatin immunoprecipitation assays. Mol. Cell Biol. 24 (2004) 5923-5936
26. Levine A.J., Feng Z., Mak T.W., You H., and Jin S. Coordination and communication between the p53 and IGF-1-AKT-TOR signal transduction pathways. Genes Dev. 20 (2006) 267-275
27. Plas D.R., and Thompson C.B. Akt-dependent transformation: there is more to growth than just surviving. Oncogene 24 (2005) 7435-7442
28. Bensaad K., Tsuruta A., Selak M.A., Vidal M.N., Nakano K., Bartrons R., Gottlieb E., and Vousden K.H. TIGAR, a p53-inducible regulator of glycolysis and apoptosis. Cell 126 (2006) 107-120
29. Kondoh H., Lleonart M.E., Gil J., Wang J., Degan P., Peters G., Martinez D., Carnero A., and Beach D. Glycolytic enzymes can modulate cellular life span. Cancer Res. 65 (2005) 177-185
30. Kim J.W., Tchernyshyov I., Semenza G.L., and Dang C.V. HIF-1-mediated expression of pyruvate dehydrogenase kinase: a metabolic switch required for cellular adaptation to hypoxia. Cell Metab. 3 (2006) 177-185
31. Papandreou I., Cairns R.A., Fontana L., Lim A.L., and Denko N.C. HIF-1 mediates adaptation to hypoxia by actively downregulating mitochondrial oxygen consumption. Cell Metab. 3 (2006) 187-197
32. Fukuda R., Zhang H., Kim J.W., Shimoda L., Dang C.V., and Semenza G.L. HIF-1 regulates cytochrome oxidase subunits to optimize efficiency of respiration in hypoxic cells. Cell 129 (2007) 111-122
33. Matoba S., Kang J.G., Patino W.D., Wragg A., Boehm M., Gavrilova O., Hurley P.J., Bunz F., and Hwang P.M. p53 regulates mitochondrial respiration. Science 312 (2006) 1650-1653
34. Zhang H., Gao P., Fukuda R., Kumar G., Krishnamachary B., Zeller K.I., Dang C.V., and Semenza G.L. HIF-1 inhibits mitochondrial biogenesis and cellular respiration in VHL-deficient renal cell carcinoma by repression of c-myc activity. Cancer Cell 11 (2007) 407-420
35. Oktay Y., Dioum E., Matsuzaki S., Ding K., Yan L.J., Haller R.G., Szweda L.I., and Garcia J.A. Hypoxia-inducible factor 2alpha regulates expression of the mitochondrial aconitase chaperone protein frataxin. J. Biol. Chem. 282 (2007) 11750-11756
36. Schieke S.M., Phillips D., McCoy Jr. J.P., Aponte A.M., Shen R.F., Balaban R.S., and Finkel T. The mammalian target of rapamycin (mTOR) pathway regulates mitochondrial oxygen consumption and oxidative capacity. J. Biol. Chem 281 (2006) 27643-27652
37. Pouyssegur J., Dayan F., and Mazure N.M. Hypoxia signalling in cancer and approaches to enforce tumour regression. Nature 441 (2006) 437-443
38. Shaw R.J., and Cantley L.C. Ras, PI(3)K and mTOR signalling controls tumour cell growth. Nature 441 (2006) 424-430
39. Hewitson K.S., Lienard B.M., McDonough M.A., Clifton I.J., Butler D., Soares A.S., Oldham N.J., McNeill L.A., and Schofield C.J. Structural and mechanistic studies on the inhibition of the hypoxia-inducible transcription factor hydroxylases by tricarboxylic acid cycle intermediates. J. Biol. Chem. 282 (2007) 3293-3301
40. Gottlieb E., and Tomlinson I.P. Mitochondrial tumour suppressors: a genetic and biochemical update. Nat. Rev. Cancer 5 (2005) 857-866
41. Mackenzie E.D., Selak M.A., Tennant D.A., Payne L.J., Crosby S., Frederiksen C.M., Watson D.G., and Gottlieb E. Cell-permeating {alpha}-ketoglutarate derivatives alleviate pseudohypoxia in succinate dehydrogenase-deficient cells. Mol. Cell Biol. 27 (2007) 3282-3289
42. Pollard P.J., Spencer-Dene B., Shukla D., Howarth K., Nye E., El-Bahrawy M., Deheragoda M., Joannou M., McDonald S., Martin A., Igarashi P., Varsani-Brown S., Rosewell I., Poulsom R., Maxwell P., Stamp G.W., and Tomlinson I.P. Targeted inactivation of fh1 causes proliferative renal cyst development and activation of the hypoxia pathway. Cancer Cell 11 (2007) 311-319
43. Kaelin W.G. Proline hydroxylation and gene expression. Annu. Rev. Biochem. 74 (2005) 115-128
44. Gerald D., Berra E., Frapart Y.M., Chan D.A., Giaccia A.J., Mansuy D., Pouyssegur J., Yaniv M., and Mechta-Grigoriou F. JunD reduces tumor angiogenesis by protecting cells from oxidative stress. Cell 118 (2004) 781-794
45. Cardone R.A., Casavola V., and Reshkin S.J. The role of disturbed pH dynamics and the Na+/H+ exchanger in metastasis. Nat. Rev. Cancer 5 (2005) 786-795
46. Counillon L., and Pouyssegur J. The expanding family of eucaryotic Na(+)/H(+) exchangers. J. Biol. Chem. 275 (2000) 1-4
47. Ullah M.S., Davies A.J., and Halestrap A.P. The plasma membrane lactate transporter MCT4, but not MCT1, is up-regulated by hypoxia through a HIF-1alpha dependent mechansm. J. Biol. Chem. 281 (2006) 9030-9037
48. Shimoda L.A., Fallon M., Pisarcik S., Wang J., and Semenza G.L. HIF-1 regulates hypoxic induction of NHE1 expression and alkalinization of intracellular pH in pulmonary arterial myocytes. Am. J. Physiol. Lung Cell Mol. Physiol. 291 (2006) L941-L949
49. Cardone R.A., Bellizzi A., Busco G., Weinman E.J., Dell'aquila M.E., Casavola V., Azzariti A., Mangia A., Paradiso A., and Reshkin S.J. The NHERF1 PDZ2 domain regulates PKA-RhoA-p38-mediated NHE1 activation and invasion in breast tumor cells. Mol. Biol. Cell 18 (2007) 1768-1780
50. Ivanov S., Liao S.Y., Ivanova A., Danilkovitch-Miagkova A., Tarasova N., Weirich G., Merrill M.J., Proescholdt M.A., Oldfield E.H., Lee J., Zavada J., Waheed A., Sly W., Lerman M.I., and Stanbridge E.J. Expression of hypoxia-inducible cell-surface transmembrane carbonic anhydrases in human cancer. Am. J. Pathol. 158 (2001) 905-919
51. Swietach P., Vaughan-Jones R.D., and Harris A.L. Regulation of tumor pH and the role of carbonic anhydrase 9. Cancer Metast. Rev. (2007)
52. Thiry A., Dogne J.M., Masereel B., and Supuran C.T. Targeting tumor-associated carbonic anhydrase IX in cancer therapy. Trends Pharmacol. Sci. 27 (2006) 566-573
53. Van den Eynden G.G., Van der Auwera I., Van Laere S.J., Colpaert C.G., Turley H., Harris A.L., van Dam P., Dirix L.Y., Vermeulen P.B., and Van Marck E.A. Angiogenesis and hypoxia in lymph node metastases is predicted by the angiogenesis and hypoxia in the primary tumour in patients with breast cancer. Br. J. Cancer 93 (2005) 1128-1136
54. Trastour C., Benizri E., Ettore F., Ramaioli A., Chamorey E., Pouyssegur J., and Berra E. HIF-1alpha and CA IX staining in invasive breast carcinomas: prognosis and treatment outcome. Int. J. Cancer 120 (2007) 1451-1458
55. Hussain S.A., Ganesan R., Reynolds G., Gross L., Stevens A., Pastorek J., Murray P.G., Perunovic B., Anwar M.S., Billingham L., James N.D., Spooner D., Poole C.J., Rea D.W., and Palmer D.H. Hypoxia-regulated carbonic anhydrase IX expression is associated with poor survival in patients with invasive breast cancer. Br. J. Cancer 96 (2007) 104-109
56. Potter C., and Harris A.L. Hypoxia inducible carbonic anhydrase IX, marker of tumour hypoxia, survival pathway and therapy target. Cell Cycle 3 (2004) 164-167
57. Becker H.M., Hirnet D., Fecher-Trost C., Sultemeyer D., and Deitmer J.W. Transport activity of MCT1 expressed in Xenopus oocytes is increased by interaction with carbonic anhydrase. J. Biol. Chem. 280 (2005) 39882-39889
58. Pouyssegur J., Franchi A., and Pages G. Novartis Found Symposium vol. 240 (2001), John Wiley & Sons, Ltd 186-196
59. Petrella B.L., Lohi J., and Brinckerhoff C.E. Identification of membrane type-1 matrix metalloproteinase as a target of hypoxia-inducible factor-2 alpha in von Hippel-Lindau renal cell carcinoma. Oncogene 24 (2005) 1043-1052
60. Walenta S., and Mueller-Klieser W.F. Lactate: mirror and motor of tumor malignancy. Semin. Radiat. Oncol. 14 (2004) 267-274
61. Pennacchietti S., Michieli P., Galluzzo M., Mazzone M., Giordano S., and Comoglio P.M. Hypoxia promotes invasive growth by transcriptional activation of the met protooncogene. Cancer Cell 3 (2003) 347-361
62. Staller P., Sulitkova J., Lisztwan J., Moch H., Oakeley E.J., and Krek W. Chemokine receptor CXCR4 downregulated by von Hippel-Lindau tumour suppressor pVHL. Nature 425 (2003) 307-311
63. Tsutsumi S., Yanagawa T., Shimura T., Kuwano H., and Raz A. Autocrine motility factor signaling enhances pancreatic cancer metastasis. Clin. Cancer Res. 10 (2004) 7775-7784
64. Greijer A.E., and van der Wall E. The role of hypoxia inducible factor 1 (HIF-1) in hypoxia induced apoptosis. J. Clin. Pathol. 57 (2004) 1009-1014
65. Semenza G.L. Targeting HIF-1 for cancer therapy. Nat. Rev. Cancer 3 (2003) 721-732
66. Webster K.A., Graham R.M., and Bishopric N.H. BNip3 and signal-specific programmed death in the heart. J. Mol. Cell Cardiol. 38 (2005) 35-45
67. Kubasiak L.A., Hernandez O.M., Bishopric N.H., and Webster K.A. Hypoxia and acidosis activate cardiac myocyte death through the Bcl-2 family protein BNIP3. Proc. Natl. Acad. Sci. USA 99 (2002) 12825-12830
68. Papandreou I., Krishna C., Kaper F., Cai D., Giaccia A.J., and Denko N.C. Anoxia is necessary for tumor cell toxicity caused by a low-oxygen environment. Cancer Res. 65 (2005) 3171-3178
69. Edinger A.L., and Thompson C.B. Death by design: apoptosis, necrosis and autophagy. Curr. Opin. Cell Biol. 16 (2004) 663-669
70. Pelicano H., Martin D.S., Xu R.H., and Huang P. Glycolysis inhibition for anticancer treatment. Oncogene 25 (2006) 4633-4646
71. Gerweck L.E., Vijayappa S., and Kozin S. Tumor pH controls the in vivo efficacy of weak acid and base chemotherapeutics. Mol. Cancer Ther. 5 (2006) 1275-1279